Taiwan FDA registration 4e3fb193a171cd235378a8a3000092ee
Longteng amphetamine in vitro reagent group
TW: 龍騰安非他命體外試劑組
Taiwan·Risk Class 2·Longteng Biotechnology Co., Ltd. new market factory·Registered Feb 17, 2020 – Feb 17, 2030ActiveRegistration details
- Analysis ID
- 4e3fb193a171cd235378a8a3000092ee
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Longteng Biotechnology Co., Ltd. new market factory
Product details
- Intended Use
- Qualitative detection of amphetamines and their metabolites in human urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3100 Anandamide Test System
- Import Information
- Domestic
Dates and status
- Registration Date
- Feb 17, 2020
- Expiry Date
- Feb 17, 2030
About this record
Access comprehensive regulatory information for Longteng amphetamine in vitro reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4e3fb193a171cd235378a8a3000092ee and manufactured by Longteng Biotechnology Co., Ltd. new market factory. The authorized representative in Taiwan is Longteng Biotechnology Co., Ltd. new market factory.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices